Avanos Medical (Avanos Medical) GF Score : 69/100 (As of May. 12, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Avanos Medical GF Score?

Avanos Medical has the GF Score of 69, which implies that the company might have Poor future performance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 7/10
2. Profitability Rank : 4/10
3. Growth Rank : 3/10
4. GF Value Rank : 8/10
5. Momentum Rank : 4/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Avanos Medical might have Poor future performance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Avanos Medical's GF Score

For the Medical Devices subindustry, Avanos Medical's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avanos Medical's GF Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Avanos Medical's GF Score distribution charts can be found below:

* The bar in red indicates where Avanos Medical's GF Score falls into.

Avanos Medical (NYSE:AVNS) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score	Performance Potential and All-in-One Screener Examples ⁽¹⁾
91 - 100	Highest outperformance potential
81 - 90	Good outperformance potential
71 - 80	Likely to have average performance
51 - 70	Poor future performance potential
0 - 50	Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Avanos Medical GF Score Related Terms

Thank you for viewing the detailed overview of Avanos Medical's GF Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Avanos Medical (Avanos Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Avanos Medical Inc (NYSE:AVNS) » Definitions » GF Score

Comparable Companies

Traded in Other Exchanges

8HH:Germany

Address

5405 Windward Parkway, Suite 100 South, Alpharetta, GA, USA, 30004

Website

https://www.avanos.com

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. The firm operates in one segment, medical devices, which primarily sells products related to pain management, IV Therapy, and respiratory and digestive health. The company divides its Medical Devices segment into two franchises: Pain Management and Chronic Care. Pain Management provides non-opioid products for acute and interventional pain, including cold and compression therapy. Chronic Care aims at addressing digestive and respiratory issues with feeding tubes and catheters. Avanos generates most of its revenue from its Chronic Care franchise and in North America.

Executives

Sudhakar Varshney	officer: SVP, Global Supply Chain	5405 WINDWARD PARKWAY, SUITE 100 SOUTH, ALPHARETTA GA 30004
Lisa Egbuonu-davis	director	C/O OMEGA HEALTHCARE INVESTORS, INC., 303 INTERNATIONAL CIRCLE, SUITE 200, HUNT VALLEY MD 21030
John Joseph Hurley	officer: Principal Accounting Officer	5405 WINDWARD PARKWAY, ALPHARETTA GA 30004
Patrick J Oleary	director	31515 BALLANTYNE CORP, C/O SPX CORP, CHARLOTTE NC 28277
Mojirade James	officer: SVP, General Counsel	5405 WINDWARD PKWY, ALPHARETTA GA 30004
Kerr Holbrook	officer: SVP, GM Chronic Care	5405 WINDWARD PKWY, ALPHARETTA GA 30004
Michael Greiner	officer: SVP - Chief Financial Officer	C/O VISTAPRINT, 95 HAYDEN AVENUE, LEXINGTON MA 02421
David Edward Ball	officer: SVP - Global Supply Chain	AVANOS MEDICAL, INC., 5405 WINDWARD PKWY, ALPHARETTA GA 30004
William David Haydon	officer: SVP, GM Pain Franchise	5405 WINDWARD PARKWAY, ALPHARETTA GA 30004
Arjun Ranjan Sarker	officer: Senior VP, International	HALYARD HEALTH, INC., 5405 WINDWARD PARKWAY, ALPHARETTA GA 30004
Gary Blackford	director	7700 FRANCE AVENUE SOUTH, EDINA MN 55435
Joseph Fralin Woody	director, officer: Chief Executive Officer	5405 WINDWARD PARKWAY, SUITE 100 SOUTH, ALPHARETTA GA 30004
Steven E Voskuil	officer: See Remarks	5405 WINDWARD PARKWAY, ALPHARETTA GA 30004
John W Wesley	director	5405 WINDWARD PARKWAY, ALPHARETTA GA 30004
John Raymond Tushar	officer: President, Global Franchises	HALYARD HEALTH, INC., 5405 WINDWARD PARKWAY, ALPHARETTA GA 30004